Spur Therapeutics
Generated by Meeveem AI
"Developing transformative gene therapies for debilitating chronic conditions"
Stevenage
•251 - 500 Employees
•Biotechnology
About Spur Therapeutics
Spur Therapeutics is a clinical stage biotechnology company pioneering genetic medicines that deliver sustained benefits through a single infusion. The company optimises every gene therapy component, from expression to viral delivery, creating treatments tailored to each disease. Its lead programme targets Gaucher disease, expanding into Parkinson's and cardiovascular conditions. By addressing protein deficiencies at their genetic source, Spur alters disease progression in ways conventional therapies cannot. The company combines advanced AAV vector engineering with precise dosing to maximise efficacy and safety. This positions gene therapy to move beyond rare disorders and establish new care standards for millions with chronic illnesses.
256
Team Members
2015
Founded
Biotechnology
Sector
On-Site
Work Environment
Our Vision
Millions of patients worldwide access genetic medicines that transform debilitating chronic conditions into manageable realities, unlocking futures previously constrained by disease progression and lifelong treatment burdens.
Our Mission
At Spur Therapeutics, our mission is to redefine what gene therapy can do.